Literature DB >> 17561963

High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study.

M Murussi1, N Campagnolo, M O Beck, J L Gross, S P Silveiro.   

Abstract

AIM: To analyse the risk factors for the development of micro- and macroalbuminuria and mortality rates in a cohort of normoalbuminuric Type 2 diabetes mellitus (DM) patients.
METHODS: In this prospective study, 193 Type 2 DM patients with urinary albumin excretion (UAE) < 20 microg/min, 96 men (50%), aged 56.5 +/- 9 years, were followed for a mean period of 8 +/- 3 years. UAE and estimated glomerular filtration rate (eGFR; Modification of Diet in Renal Disease) were measured. The outcomes were development of persistent micro- and macroalbuminuria and mortality.
RESULTS: Twenty patients were lost to follow-up. Of the 173 remaining patients, 33 (19%) died. The Cox analysis [hazard ratio (HR), 95% confidence interval] revealed that the baseline significant predictors of mortality were higher UAE [above median (5 microg/min); HR 2.7, 1.2-6.1; P = 0.02], male sex (HR 3.9, 1.7-9.2; P = 0.002), age (HR 1.6, 1.3-1.9; P = 0.0001), and fasting plasma glucose (HR 1.2, 1.1-1.3; P = 0.004). Smoking and eGFR were not significant in this model. Follow-up renal data were available for 158 patients: 34 (22%) progressed to microalbuminuria and seven (4%) to macroalbuminuria, and the baseline predictors were a higher UAE (> 5 microg/min, HR 2.5, 1.2-5.1; P = 0.02), presence of diabetic retinopathy (HR 2.5, 1.3-5.0; P = 0.009), fasting glucose (HR 1.1, 1.0-1.2; P = 0.015), and male sex (HR 2.2, 1.1-4.7; P = 0.04), independently of smoking and hypertension. Lower GFR (HR 0.98, 0.97-1.00; P = 0.07) was of borderline significance.
CONCLUSIONS: In normoalbuminuric Type 2 DM patients, the development of micro- or macroalbuminuria and mortality rates was independently and positively associated with higher levels of albuminuria, although still in the traditionally established normal range.

Entities:  

Mesh:

Year:  2007        PMID: 17561963     DOI: 10.1111/j.1464-5491.2007.02209.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  14 in total

Review 1.  Clinical impact of albuminuria in diabetic nephropathy.

Authors:  Takashi Wada; Miho Shimizu; Tadashi Toyama; Akinori Hara; Shuichi Kaneko; Kengo Furuichi
Journal:  Clin Exp Nephrol       Date:  2011-08-10       Impact factor: 2.801

Review 2.  Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 10.121

3.  Predictors of incident albuminuria in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Ashish Upadhyay; James B Meigs; Caroline S Fox
Journal:  Am J Kidney Dis       Date:  2010-11       Impact factor: 8.860

4.  The relation of postprandial plasma glucose and serum endostatin to the urinary albumin excretion of residents with prediabetes: results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  Motohiro Shimizu; Norihiro Furusyo; Yuuki Tanaka; Yoshifumi Kato; Fujiko Mitsumoto-Kaseida; Koji Takayama; Kazuya Ura; Satoshi Hiramine; Takeo Hayashi; Hiroaki Ikezaki; Takeshi Ihara; Haru Mukae; Eiichi Ogawa; Kazuhiro Toyoda; Mosaburo Kainuma; Masayuki Murata; Jun Hayashi
Journal:  Int Urol Nephrol       Date:  2016-03-16       Impact factor: 2.370

5.  Effect of cilnidipine on normal to marginally elevated urine albumin-creatinine ratio in asymptomatic non-diabetic hypertensive patients: an exponential decay curve analysis.

Authors:  Takaaki Nakatsu; Shinji Toyonaga; Keiichi Mashima; Yoko Yuki; Aya Nishitani; Hiroko Ogawa; Toru Miyoshi; Satoshi Hirohata; Reishi Izumi; Shozo Kusachi
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

6.  The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial.

Authors:  David R Jacobs; Myron D Gross; Lyn Steffen; Michael W Steffes; Xinhua Yu; Laura P Svetkey; Lawrence J Appel; William M Vollmer; George A Bray; Thomas Moore; Paul R Conlin; Frank Sacks
Journal:  Am J Kidney Dis       Date:  2009-01-23       Impact factor: 8.860

7.  A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients.

Authors:  Haibing Chen; Zhi Zheng; Yan Huang; Kaifeng Guo; Junxi Lu; Lei Zhang; Haoyong Yu; Yuqian Bao; Weiping Jia
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

8.  Association of renal biomarkers with 3-month and 1-year outcomes among critically ill acute stroke patients.

Authors:  Ying-Chih Huang; Yi-Ling Wu; Ming-Hsueh Lee; Jiann-Der Lee; Chih-Ying Wu; Huan-Lin Hsu; Ya-Hui Lin; Yen-Chu Huang; Wen-Hung Huang; Hsu-Huei Weng; Jen-Tsung Yang; Meng Lee; Bruce Ovbiagele
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

9.  Association of urinary albumin excretion with periodontal parameters in patients with type 2 diabetes mellitus: a cross-sectional study.

Authors:  Michio Tanaka; Tatsuo Yamamoto; Nobuichi Kuribayashi; Fuminobu Okuguchi; Haruhiko Isotani; Masahiro Iwamoto; Hidekatsu Sugimoto; Osamu Nakagawa; Daisuke Suzuki; Katsushige Abe; Nobuaki Watanabe; Masato Minabe; Shinya Fuchida; Hiroki Yokoyama
Journal:  Diabetol Int       Date:  2019-10-16

10.  Monocyte chemotactic protein-1 (MCP-1) in patients with chronic schistosomiasis mansoni: evidences of subclinical renal inflammation.

Authors:  Ana Lúcia P Hanemann; Alexandre B Libório; Elizabeth F Daher; Alice Maria C Martins; Marta Cristhiany C Pinheiro; Mariana S Sousa; Fernando Schemelzer M Bezerra
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.